Articles
This article discusses ongoing clinical investigations of the agent in a wide range of therapeutic areas. Read More ›
Bendamustine is currently approved for the treatment of chronic lymphocytic leukemia (CLL), and many ongoing studies are investigating its efficacy in drug combinations. Read More ›
Bendamustine has demonstrated activity as monotherapy and in combination for patients with lymphoid and hematologic as well as solid tumors. Read More ›
At the 54th Annual Meeting of the American Society of Hematology, a number of abstracts were presented demonstrating the efficacy and toxicities of bendamustine either alone or in combination with other agents for the treatment of several lymphoid malignancies such as chronic lymphocytic leukemia (CLL) and indolent as well as aggressive non-Hodgkin lymphoma (NHL). Read More ›
Scientists at Baylor Research Institute have created a simple blood test that aids in the detection of colorectal cancer. Read More ›
Identification technique involves single nucleotide polymorphisms. Read More ›
University of Pennsylvania researchers compare the benefits of PET-CT scans and bone scans with regard to initial assessment of patients with limited-stage small-cell lung cancer (SCLC). Read More ›
Study shows diagnosis and treatment discrepancies exist between urban and rural women with breast cancer. Read More ›
In this issue of Conquering the Cancer Care Continuum, Ms Faiman and Dr Stricker focus on aspects of treatment planning in cancer patients. While they come at the topic from slightly different angles, both cases illustrate that deciding on whether to treat patients, which drugs to use, and what other supportive medications to consider is not a simple cookbook process. In this commentary, I will provide a perspective on my conversations with patients and then discuss some pressing issues that are emerging in this area. Read More ›
The fourth issue of Conquering the Cancer Care Continuum series addresses Treatment Planning Through the Cancer Care Continuum. Following are 2 key articles to provide insight into the role of the clinical pharmacologist as a member of the multidisciplinary team working collaboratively to render recommendations about treatment planning options. Gone are the days, or they should be, when oncology specialists merely passed on – either on paper or electronically – prescription instructions to be filled by the pharmacologist or pharmacist. These individuals, experts in drug management, interaction, and optimization, are integral to the oncology care team. You will soon read and learn why. Read More ›